You are here

  • Home
  • Archive
  • Volume 77, Issue 2
  • Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Concise report
Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: November 2017 to March 2024

AbstractFullPdf
Nov 2017869888397
Dec 201714281462387
Jan 2018807825204
Feb 2018366353163
Mar 201825825071
Apr 201816816886
May 201813313739
Jun 201817117627
Jul 2018767624
Aug 2018676726
Sep 2018616128
Oct 2018808014
Nov 2018868623
Dec 2018929222
Jan 2019696815
Feb 2019605928
Mar 2019666026
Apr 2019312925
May 2019434213
Jun 2019454220
Jul 2019494820
Aug 2019535139
Sep 2019535022
Oct 2019494822
Nov 2019484713
Dec 2019645822
Jan 2020686721
Feb 2020817635
Mar 2020949052
Apr 2020858425
May 2020888637
Jun 2020928919
Jul 2020828023
Aug 2020807620
Sep 2020868522
Oct 2020868324
Nov 2020918222
Dec 2020595714
Jan 2021545122
Feb 2021494812
Mar 2021878439
Apr 2021565115
May 2021605318
Jun 202143426
Jul 202148469
Aug 2021605824
Sep 2021454313
Oct 2021716733
Nov 2021424035
Dec 2021484517
Jan 202249449
Feb 2022363610
Mar 2022474422
Apr 2022747124
May 2022746819
Jun 2022646218
Jul 2022757114
Aug 202247434
Sep 2022787321
Oct 2022565611
Nov 2022524721
Dec 2022625810
Jan 2023515012
Feb 2023878311
Mar 202314139
Apr 2023212017
May 2023312918
Jun 2023242410
Jul 2023333421
Aug 2023333219
Sep 202325259
Oct 202335348
Nov 202332312
Dec 2023424110
Jan 2024393013
Feb 2024484314
Mar 2024322799
Total820880952788